2.50
Hdl Handle:
http://hdl.handle.net/10541/86535
Title:
Management of elderly patients with lung cancer.
Authors:
Ranson, Malcolm R; White, Shane C; Thatcher, Nick
Abstract:
Cancer management in the older patient is a growing concern, particularly with the increasing geriatric population and the high incidence of cancer among these individuals. Incidence of lung cancer in particular is known to rise with age. This article reviews prognosis, treatment options, and decision-making issues for both clinician and patient with respect to both non-small-cell and small-cell lung cancer in this population. Research findings dealing with response rates, survival rates, and symptom control in this age group are reviewed for radiotherapy, surgery, and for various chemotherapy agents, including gemcitabine, the taxanes, vinorelbine, and the topoisomerase 1 inhibitors. Quality- of-life issues are also addressed.
Affiliation:
Department of Medical Oncology, Christie Hospital NHS Trust and Holt Radium Institute, Wilmslow Road, Manchester M20 4BX, United Kingdom.
Citation:
Management of elderly patients with lung cancer. 2000, 2 (1):90-5 Curr Oncol Rep
Journal:
Current Oncology Reports
Issue Date:
Jan-2000
URI:
http://hdl.handle.net/10541/86535
DOI:
10.1007/s11912-000-0015-y
PubMed ID:
11122829
Type:
Article
Language:
en
ISSN:
1523-3790
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorRanson, Malcolm Ren
dc.contributor.authorWhite, Shane Cen
dc.contributor.authorThatcher, Nicken
dc.date.accessioned2009-11-19T17:02:22Z-
dc.date.available2009-11-19T17:02:22Z-
dc.date.issued2000-01-
dc.identifier.citationManagement of elderly patients with lung cancer. 2000, 2 (1):90-5 Curr Oncol Repen
dc.identifier.issn1523-3790-
dc.identifier.pmid11122829-
dc.identifier.doi10.1007/s11912-000-0015-y-
dc.identifier.urihttp://hdl.handle.net/10541/86535-
dc.description.abstractCancer management in the older patient is a growing concern, particularly with the increasing geriatric population and the high incidence of cancer among these individuals. Incidence of lung cancer in particular is known to rise with age. This article reviews prognosis, treatment options, and decision-making issues for both clinician and patient with respect to both non-small-cell and small-cell lung cancer in this population. Research findings dealing with response rates, survival rates, and symptom control in this age group are reviewed for radiotherapy, surgery, and for various chemotherapy agents, including gemcitabine, the taxanes, vinorelbine, and the topoisomerase 1 inhibitors. Quality- of-life issues are also addressed.en
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshAge Factors-
dc.subject.meshAged-
dc.subject.meshAntineoplastic Agents, Phytogenic-
dc.subject.meshBridged Compounds-
dc.subject.meshCarcinoma, Non-Small-Cell Lung-
dc.subject.meshCarcinoma, Small Cell-
dc.subject.meshCombined Modality Therapy-
dc.subject.meshDecision Making-
dc.subject.meshDeoxycytidine-
dc.subject.meshGeriatrics-
dc.subject.meshHumans-
dc.subject.meshLung Neoplasms-
dc.subject.meshPrognosis-
dc.subject.meshQuality of Life-
dc.subject.meshSurvival Analysis-
dc.subject.meshTaxoids-
dc.subject.meshVinblastine-
dc.titleManagement of elderly patients with lung cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital NHS Trust and Holt Radium Institute, Wilmslow Road, Manchester M20 4BX, United Kingdom.en
dc.identifier.journalCurrent Oncology Reportsen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.